MENU
September 29 and 30, 2020 Starts at 6am PDT, 9am EDT, 2pm BST, 3pm CEST, 4pm EEST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Applied Biosystems Genetic Analysis Virtual Conference

Due to the fact that many large events and scientific conferences have been cancelled, we want to provide you with an outlet to present your research and learn from others in our community.

 

A key to scientific exploration is not just getting answers, it’s about formulating the right questions that will make a difference in the world. We want to inspire you to ask questions that make a difference. Because the most important thing you can do is ask another question. Without constant questioning, world-changing discoveries cannot be found.

 

To this end, we are excited to announce our Applied Biosystems Genetic Analysis Virtual Conference. This is a virtual, online event occurring on September 29-30, 2020, and serves as an opportunity for you to engage with us and other scientists, and to Ask.

 

We are bringing together experts to present talks and posters across a broad range of genetic analysis fields, including:

  • Viral testing and molecular diagnostics

  • Infectious disease research

  • Clinical oncology and Cancer research

  • Reproductive health and Inherited disease research

  • Polygenic risk scores and Population health

  • Pharmacogenomics research

  • Agrigenomics and Animal health

 

We will also have an Ask an Expert lounge, instrument demonstration hall, and exhibit hall that will showcase our platform technologies such as real-time PCR, next-generation and Sanger sequencing, and microarray analysis. In addition to insights gained in these fields, continuing education credits will be offered to those presentations that qualify.


Speakers

Show Resources
You May Also Like
SEP 23, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 23, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Please join us at the 9th Annual Fluidigm Mass Cytometry Virtual Summit This yearly international meeting of the mass cytometry community is designed for new and experienced users, as well a...
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Ten years ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2020 Clinical Diagnostics and Research Virtual Event will again bring together clinicians,...
OCT 28, 2020 7:00 AM GMT, 12:30PM IST, 3:00PM SGT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
OCT 28, 2020 7:00 AM GMT, 12:30PM IST, 3:00PM SGT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Each step in a diagnostic test's journey-from raw material extraction to patient administration-can influence outcomes....
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 7 th Ann...
NOV 11, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 11, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Twelveyears ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event will again bring together clinician...
SEP 29, 2020 2:00 PM EDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 29, 2020 2:00 PM EDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
2nd ANNUAL PAWS FOR A CURE VIRTUAL EVENT RESEARCH SYMPOSIUM Translational Potential Of Comparative Approaches To Accelerate Drug Development In Shared Childhood & Canine Cancers We are...
Agenda
  • Animal Health Sample Extraction
    SEP 29, 2020 6:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Animal Health Sample Extraction
    Derek Grillo
    Sr Product Manager - Thermo Fisher Scientific
  • Debunking the Challenges of PGx Clinical Research Implementation
    SEP 29, 2020 6:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Debunking the Challenges of PGx Clinical Research Implementation
    Anna Dominiczak, DBE MD FRCP FAHA FRSE FMedSci
    Regius Professor of Medicine, Vice Principal and Head of the College of Medical, Veterinary & Life Sciences - University of Glasgow
  • Fireside chat: When COVID-19 meets RSV and flu season
    SEP 29, 2020 6:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Fireside chat: When COVID-19 meets RSV and flu season
    Manoj Ghandi, MD, PhD
    Sr. Director, Medical Affairs, Genetic Testing Solutions - Thermo Fisher Scientific
  • African Swine Fever - How real-time PCR testing is used in China?
    SEP 29, 2020 6:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    African Swine Fever - How real-time PCR testing is used in China?
    Li Xiang, PhD
    Technical Manager from China Animal Husbandry Group
  • Clariom D application in breast cancer
    SEP 29, 2020 6:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Clariom D application in breast cancer
    Yesim Gokem-Polar, PhD
    Associate Research Professor - Indiana University School of Medicine
  • Preemptive PGx at Population-Scale: Implementation in Pittsburgh
    SEP 29, 2020 6:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Preemptive PGx at Population-Scale: Implementation in Pittsburgh
    Philip Empey, PharmD, PhD
    Director, Pharmacogenomics Center of Excellence; Associate Director, Institute for Precision Medicine - University of Pittsburgh
  • High-throughput, low-cost transcriptome profiling with the Clariom GO Screen Assay
    SEP 29, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    High-throughput, low-cost transcriptome profiling with the Clariom GO Screen Assay
    Anthony Schweitzer
    Director, Expression Bioinformatics, Microarrays - Thermo Fisher Scientific
  • Improve Lives, Reduce Costs and Simplify Decision-Making: Enterprise Pharmacogenomics
    SEP 29, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Improve Lives, Reduce Costs and Simplify Decision-Making: Enterprise Pharmacogenomics
    Jeffrey Shaman, PhD, MS
    Chief Science Officer - Coriell Life Sciences
  • AgriSeq™ - Fast and Affordable Genotyping by Sequencing Solution for Breeding Programs
    SEP 29, 2020 7:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    AgriSeq™ - Fast and Affordable Genotyping by Sequencing Solution for Breeding Programs
    Srinivas Chadaram, PhD
    Sr. Product Manager, Agrigenomics - Thermo Fisher Scientific
  • Announcing the Thermo Fisher Scientific™ Amplitude™ Solution: High-Throughput, Highly Automated COVID-19 Testing
    SEP 29, 2020 7:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Announcing the Thermo Fisher Scientific™ Amplitude™ Solution: High-Throughput, Highly Automated COVID-19 Testing
    Hannah Pezzi, PhD
    Staff Scientist, Genetic Testing Solutions - Thermo Fisher Scientific
  • Quality control of human cell lines and other ex vivo-manipulated human samples
    SEP 29, 2020 7:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Quality control of human cell lines and other ex vivo-manipulated human samples
    Steve Jackson, PhD
    Senior Manager, Product Applications - Thermo Fisher Scientific
  • The Landscape of Pharmacogenetic Resources
    SEP 29, 2020 7:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    The Landscape of Pharmacogenetic Resources
    Andrea Gaedigk, PhD
    Director, Pharmacogenomics Core Laboratory in the Division of Clinical Pharmacology & Medical Toxicology, Children's Mercy Kansas City; Professor of Pediatrics, University of Missouri-Kansas
  • Clinical Laboratory Experience with TaqPath COVID-19 Testing
    SEP 29, 2020 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Clinical Laboratory Experience with TaqPath COVID-19 Testing
    Scott Hunicke-Smith, PhD
    Scientific Director - Clinical Pathology Laboratories
  • Design and first Results from an Axiom custom SNP-array for Swiss cattle
    SEP 29, 2020 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Design and first Results from an Axiom custom SNP-array for Swiss cattle
    Franz Seefried, PhD
    Senior Geneticist - QUALITAS
  • How Comprehensive Pharmacogenomics Accelerates Personalized Therapies and Reduces Health Disparities for Minorities
    SEP 29, 2020 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    How Comprehensive Pharmacogenomics Accelerates Personalized Therapies and Reduces Health Disparities for Minorities
    Ulrich Broeckel, MD
    CEO and Founder of RPRD Diagnostics; Professor at Medical College of Wisconsin - RPRD Diagnostics
  • Genetic technologies for the discovery and verification of cancer immunotherapy biomarkers
    SEP 29, 2020 8:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Genetic technologies for the discovery and verification of cancer immunotherapy biomarkers
    Harita Veereshlingam, PhD
    Senior Product Application Scientist, Genetic Sciences Division - Thermo Fisher Scientific
  • Technical Advances in Octoploid Strawberry Genomics and Genome-Informed Breeding
    SEP 29, 2020 8:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Technical Advances in Octoploid Strawberry Genomics and Genome-Informed Breeding
    Steven J. Knapp
    Professor and Director of the University of California, Davis Strawberry Breeding Program
  • Technology Overview: How to Select a Pharmacogenomics Platform for Clinical Research
    SEP 29, 2020 8:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Technology Overview: How to Select a Pharmacogenomics Platform for Clinical Research
    Jami Elliott, MS, MBA
    Director, Business Development - Thermo Fisher Scientific
  • A conversation-What happens when COVID-19 meets flu season?
    SEP 29, 2020 9:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    A conversation-What happens when COVID-19 meets flu season?
    Manoj Ghandi, MD, PhD
    Sr. Director, Medical Affairs, Genetic Testing Solutions - Thermo Fisher Scientific
  • Verifying immunooncology-related gene expression patterns in colon tumor research samples using RFID-tagged TaqMan panels
    SEP 29, 2020 9:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Verifying immunooncology-related gene expression patterns in colon tumor research samples using RFID-tagged TaqMan panels
    Steve Jackson, PhD
    Senior Manager, Product Applications - Thermo Fisher Scientific
  • Comprehensive set of solutions for advancing SARS-CoV-2 research
    SEP 30, 2020 6:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Comprehensive set of solutions for advancing SARS-CoV-2 research
    Alain Rico
    Sr Manager, Market Development - Thermo Fisher Scientific
  • Contribution of Chromosomal Microarrays to Precision Medicine in the Clinical Laboratory
    SEP 30, 2020 6:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Contribution of Chromosomal Microarrays to Precision Medicine in the Clinical Laboratory
    Laila Mnayer, MS, PhD, FACMG
    Division Director, Molecular Pathology & Cytogenetics - Hartford Hospital, Hartford Healthcare
  • Towards antibody-based treatment of COVID-19 - A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes
    SEP 30, 2020 6:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Towards antibody-based treatment of COVID-19 - A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes
    Ohad Mazor, PhD
    Head, the Department of Infectious diseases - IIBR
  • SARS-CoV-2 and co-infections: A detailed survey of viral and bacterial respiratory pathogens
    SEP 30, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    SARS-CoV-2 and co-infections: A detailed survey of viral and bacterial respiratory pathogens
    Vijay Singh, PhD
    Managing Principal Scientist , Molecular Diagnostics, HealthTrack, Rx
  • The Road to Widespread Application of Polygenic Risk Scores in Health Care Delivery Decision Making
    SEP 30, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    The Road to Widespread Application of Polygenic Risk Scores in Health Care Delivery Decision Making
    Andy Peterson, PhD
    Chief Scientific Officer - MedGenome Inc.
  • Updates on the Use of Broad-Spectrum Copy Number Data in the Clinical Workup of CNS Neoplasia
    SEP 30, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Updates on the Use of Broad-Spectrum Copy Number Data in the Clinical Workup of CNS Neoplasia
    Stewart G Neill, MD
    Assistant Professor, Pathology & Laboratory Medicine, Associate Director, Pathology Residency Program, Emory University
  • miRNA biomarker discovery in cardiovascular research
    SEP 30, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    miRNA biomarker discovery in cardiovascular research
    Yuri D'Alessandra
    Sr. Researcher, Immunology and Functional Genomics Unit - Centro Cardiologico Monzino
  • Advancing Reproductive Health Through Innovative Genetic Analysis Solutions
    SEP 30, 2020 7:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Advancing Reproductive Health Through Innovative Genetic Analysis Solutions
    George Hii
    Director, Global Market Development and Marketing, Reproductive Health - Thermo Fisher Scientific
  • Investigating genetic diversity in the VA's Million Veteran Program (MVP)
    SEP 30, 2020 7:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Investigating genetic diversity in the VA's Million Veteran Program (MVP)
    Saiju Pyarajan, PhD
    Director - Veteran Affairs
  • SEP 30, 2020 7:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Two distinct immunopathological profiles in autopsy lungs of SARS-CoV-2
    Viktor Kölzer, PhD
    Senior Clinical Researcher, University of Oxford
    Ronny Neinhold
    Group Head in Molecular Pathology - Institute of Pathol...
  • Cancer Genomics: What We Can Learn from Africa
    SEP 30, 2020 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Cancer Genomics: What We Can Learn from Africa
    Timothy Rebbeck
    Professor of Cancer Prevention at the Harvard T.H. Chan School of Public Health and the Dana-Farber Cancer Institute
  • Importance of MSI Using Liquid Biopsy for Studying Immunotherapy
    SEP 30, 2020 8:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Importance of MSI Using Liquid Biopsy for Studying Immunotherapy
    Paul R. Walker, MD, FACP
    Chief Medical Officer - Circulogene
  • Polygenic Risk Score analysis for Alzheimer's disease risk
    SEP 30, 2020 9:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Polygenic Risk Score analysis for Alzheimer's disease risk
    Richard Pither, PhD
    CEO, Cytox Ltd, United Kingdom
  • The role of Sanger sequencing and fragment analysis by capillary electrophoresis in the fight against COVID-19
    SEP 30, 2020 9:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    The role of Sanger sequencing and fragment analysis by capillary electrophoresis in the fight against COVID-19
    Steve Williams
    R&D Leader, Capillary Electrophoresis - Thermo Fisher Scientific
  • Common risk variants and complex disorders
    SEP 30, 2020 9:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Common risk variants and complex disorders
    David C. Whitcomb, MD, PhD, FACP, FACG, AGAG
    Professor, Co-Founder Ariel Precision Medicine - Ariel Precision Medicine
  • Pharmacogenomics
  • Debunking the Challenges of PGx Clinical Research Implementation
    SEP 29, 2020 6:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Debunking the Challenges of PGx Clinical Research Implementation
    Anna Dominiczak, DBE MD FRCP FAHA FRSE FMedSci
    Regius Professor of Medicine, Vice Principal and Head of the College of Medical, Veterinary & Life Sciences - University of Glasgow
  • Preemptive PGx at Population-Scale: Implementation in Pittsburgh
    SEP 29, 2020 6:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Preemptive PGx at Population-Scale: Implementation in Pittsburgh
    Philip Empey, PharmD, PhD
    Director, Pharmacogenomics Center of Excellence; Associate Director, Institute for Precision Medicine - University of Pittsburgh
  • Improve Lives, Reduce Costs and Simplify Decision-Making: Enterprise Pharmacogenomics
    SEP 29, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Improve Lives, Reduce Costs and Simplify Decision-Making: Enterprise Pharmacogenomics
    Jeffrey Shaman, PhD, MS
    Chief Science Officer - Coriell Life Sciences
  • The Landscape of Pharmacogenetic Resources
    SEP 29, 2020 7:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    The Landscape of Pharmacogenetic Resources
    Andrea Gaedigk, PhD
    Director, Pharmacogenomics Core Laboratory in the Division of Clinical Pharmacology & Medical Toxicology, Children's Mercy Kansas City; Professor of Pediatrics, University of Missouri-Kansas
  • How Comprehensive Pharmacogenomics Accelerates Personalized Therapies and Reduces Health Disparities for Minorities
    SEP 29, 2020 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    How Comprehensive Pharmacogenomics Accelerates Personalized Therapies and Reduces Health Disparities for Minorities
    Ulrich Broeckel, MD
    CEO and Founder of RPRD Diagnostics; Professor at Medical College of Wisconsin - RPRD Diagnostics
  • Technology Overview: How to Select a Pharmacogenomics Platform for Clinical Research
    SEP 29, 2020 8:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Technology Overview: How to Select a Pharmacogenomics Platform for Clinical Research
    Jami Elliott, MS, MBA
    Director, Business Development - Thermo Fisher Scientific
  • COVID 19 Diagnostics
  • Fireside chat: When COVID-19 meets RSV and flu season
    SEP 29, 2020 6:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Fireside chat: When COVID-19 meets RSV and flu season
    Manoj Ghandi, MD, PhD
    Sr. Director, Medical Affairs, Genetic Testing Solutions - Thermo Fisher Scientific
  • Announcing the Thermo Fisher Scientific™ Amplitude™ Solution: High-Throughput, Highly Automated COVID-19 Testing
    SEP 29, 2020 7:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Announcing the Thermo Fisher Scientific™ Amplitude™ Solution: High-Throughput, Highly Automated COVID-19 Testing
    Hannah Pezzi, PhD
    Staff Scientist, Genetic Testing Solutions - Thermo Fisher Scientific
  • Clinical Laboratory Experience with TaqPath COVID-19 Testing
    SEP 29, 2020 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Clinical Laboratory Experience with TaqPath COVID-19 Testing
    Scott Hunicke-Smith, PhD
    Scientific Director - Clinical Pathology Laboratories
  • A conversation-What happens when COVID-19 meets flu season?
    SEP 29, 2020 9:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    A conversation-What happens when COVID-19 meets flu season?
    Manoj Ghandi, MD, PhD
    Sr. Director, Medical Affairs, Genetic Testing Solutions - Thermo Fisher Scientific
  • AgriBusiness
  • Animal Health Sample Extraction
    SEP 29, 2020 6:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Animal Health Sample Extraction
    Derek Grillo
    Sr Product Manager - Thermo Fisher Scientific
  • African Swine Fever - How real-time PCR testing is used in China?
    SEP 29, 2020 6:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    African Swine Fever - How real-time PCR testing is used in China?
    Li Xiang, PhD
    Technical Manager from China Animal Husbandry Group
  • AgriSeq™ - Fast and Affordable Genotyping by Sequencing Solution for Breeding Programs
    SEP 29, 2020 7:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    AgriSeq™ - Fast and Affordable Genotyping by Sequencing Solution for Breeding Programs
    Srinivas Chadaram, PhD
    Sr. Product Manager, Agrigenomics - Thermo Fisher Scientific
  • Design and first Results from an Axiom custom SNP-array for Swiss cattle
    SEP 29, 2020 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Design and first Results from an Axiom custom SNP-array for Swiss cattle
    Franz Seefried, PhD
    Senior Geneticist - QUALITAS
  • Technical Advances in Octoploid Strawberry Genomics and Genome-Informed Breeding
    SEP 29, 2020 8:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Technical Advances in Octoploid Strawberry Genomics and Genome-Informed Breeding
    Steven J. Knapp
    Professor and Director of the University of California, Davis Strawberry Breeding Program
  • Cancer Research
  • Clariom D application in breast cancer
    SEP 29, 2020 6:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Clariom D application in breast cancer
    Yesim Gokem-Polar, PhD
    Associate Research Professor - Indiana University School of Medicine
  • High-throughput, low-cost transcriptome profiling with the Clariom GO Screen Assay
    SEP 29, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    High-throughput, low-cost transcriptome profiling with the Clariom GO Screen Assay
    Anthony Schweitzer
    Director, Expression Bioinformatics, Microarrays - Thermo Fisher Scientific
  • Quality control of human cell lines and other ex vivo-manipulated human samples
    SEP 29, 2020 7:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Quality control of human cell lines and other ex vivo-manipulated human samples
    Steve Jackson, PhD
    Senior Manager, Product Applications - Thermo Fisher Scientific
  • Genetic technologies for the discovery and verification of cancer immunotherapy biomarkers
    SEP 29, 2020 8:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Genetic technologies for the discovery and verification of cancer immunotherapy biomarkers
    Harita Veereshlingam, PhD
    Senior Product Application Scientist, Genetic Sciences Division - Thermo Fisher Scientific
  • Verifying immunooncology-related gene expression patterns in colon tumor research samples using RFID-tagged TaqMan panels
    SEP 29, 2020 9:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Verifying immunooncology-related gene expression patterns in colon tumor research samples using RFID-tagged TaqMan panels
    Steve Jackson, PhD
    Senior Manager, Product Applications - Thermo Fisher Scientific
  • Infectious Disease and SARS-CoV-2 Research
  • Comprehensive set of solutions for advancing SARS-CoV-2 research
    SEP 30, 2020 6:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Comprehensive set of solutions for advancing SARS-CoV-2 research
    Alain Rico
    Sr Manager, Market Development - Thermo Fisher Scientific
  • Towards antibody-based treatment of COVID-19 - A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes
    SEP 30, 2020 6:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Towards antibody-based treatment of COVID-19 - A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes
    Ohad Mazor, PhD
    Head, the Department of Infectious diseases - IIBR
  • SARS-CoV-2 and co-infections: A detailed survey of viral and bacterial respiratory pathogens
    SEP 30, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    SARS-CoV-2 and co-infections: A detailed survey of viral and bacterial respiratory pathogens
    Vijay Singh, PhD
    Managing Principal Scientist , Molecular Diagnostics, HealthTrack, Rx
  • SEP 30, 2020 7:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Two distinct immunopathological profiles in autopsy lungs of SARS-CoV-2
    Viktor Kölzer, PhD
    Senior Clinical Researcher, University of Oxford
    Ronny Neinhold
    Group Head in Molecular Pathology - Institute of Pathol...
  • The role of Sanger sequencing and fragment analysis by capillary electrophoresis in the fight against COVID-19
    SEP 30, 2020 9:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    The role of Sanger sequencing and fragment analysis by capillary electrophoresis in the fight against COVID-19
    Steve Williams
    R&D Leader, Capillary Electrophoresis - Thermo Fisher Scientific
  • Clinical Oncology
  • Contribution of Chromosomal Microarrays to Precision Medicine in the Clinical Laboratory
    SEP 30, 2020 6:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Contribution of Chromosomal Microarrays to Precision Medicine in the Clinical Laboratory
    Laila Mnayer, MS, PhD, FACMG
    Division Director, Molecular Pathology & Cytogenetics - Hartford Hospital, Hartford Healthcare
  • Updates on the Use of Broad-Spectrum Copy Number Data in the Clinical Workup of CNS Neoplasia
    SEP 30, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Updates on the Use of Broad-Spectrum Copy Number Data in the Clinical Workup of CNS Neoplasia
    Stewart G Neill, MD
    Assistant Professor, Pathology & Laboratory Medicine, Associate Director, Pathology Residency Program, Emory University
  • Importance of MSI Using Liquid Biopsy for Studying Immunotherapy
    SEP 30, 2020 8:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Importance of MSI Using Liquid Biopsy for Studying Immunotherapy
    Paul R. Walker, MD, FACP
    Chief Medical Officer - Circulogene
  • Polygenic Risk Score & Population Health
  • The Road to Widespread Application of Polygenic Risk Scores in Health Care Delivery Decision Making
    SEP 30, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    The Road to Widespread Application of Polygenic Risk Scores in Health Care Delivery Decision Making
    Andy Peterson, PhD
    Chief Scientific Officer - MedGenome Inc.
  • Investigating genetic diversity in the VA's Million Veteran Program (MVP)
    SEP 30, 2020 7:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Investigating genetic diversity in the VA's Million Veteran Program (MVP)
    Saiju Pyarajan, PhD
    Director - Veteran Affairs
  • Cancer Genomics: What We Can Learn from Africa
    SEP 30, 2020 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Cancer Genomics: What We Can Learn from Africa
    Timothy Rebbeck
    Professor of Cancer Prevention at the Harvard T.H. Chan School of Public Health and the Dana-Farber Cancer Institute
  • Polygenic Risk Score analysis for Alzheimer's disease risk
    SEP 30, 2020 9:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Polygenic Risk Score analysis for Alzheimer's disease risk
    Richard Pither, PhD
    CEO, Cytox Ltd, United Kingdom
  • Common risk variants and complex disorders
    SEP 30, 2020 9:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Common risk variants and complex disorders
    David C. Whitcomb, MD, PhD, FACP, FACG, AGAG
    Professor, Co-Founder Ariel Precision Medicine - Ariel Precision Medicine
  • Reproductive Health and Inherited Disease Research
  • miRNA biomarker discovery in cardiovascular research
    SEP 30, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    miRNA biomarker discovery in cardiovascular research
    Yuri D'Alessandra
    Sr. Researcher, Immunology and Functional Genomics Unit - Centro Cardiologico Monzino
  • Advancing Reproductive Health Through Innovative Genetic Analysis Solutions
    SEP 30, 2020 7:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Advancing Reproductive Health Through Innovative Genetic Analysis Solutions
    George Hii
    Director, Global Market Development and Marketing, Reproductive Health - Thermo Fisher Scientific
Speakers

  • Ulrich Broeckel, MD
    CEO and Founder of RPRD Diagnostics; Professor at Medical College of Wisconsin - RPRD Diagnostics
    Biography

      Ulrich Broeckel, MD, is a leading physician-scientist with over 20 years of experience in genetics and genomics and more than 10 years of experience in clinical diagnostics. He is an expert in translational pharmacogenomics research and is a member of the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the NIH initiatives on clinical pharmacogenomics. Dr. Broeckel also serves as Professor of Pediatrics, Section Chief of Genomic Pediatrics, and Associate Director for Pharmacogenomics, Genomic Sciences, and Precision Medicine Center at the Medical College of Wisconsin.

    • Srinivas Chadaram, PhD
      Sr. Product Manager, Agrigenomics - Thermo Fisher Scientific
      Biography

        Dr. Srinivas Chadaram joined Thermo Fisher Scientific, in 2018, as a Sr. Product Manager, Agrigenomics, in the AgriBusiness Vertical. In this role, he is responsible for the portfolio of products supporting Agrigenomics vertical - including AgriSeq GBS and CE and working with the qPCR and microarrays teams supporting Agrigenomics solutions. Srinivas is based in the Austin, TX. Srinivas brings extensive experience to Thermo Fisher Scientific, with a strong healthcare and life Sciences background. He has been involved in several startups primarily helping in new product & solution development, starting from requirements gathering to commercialization of products. As a product manager at Advanced Liquid Logic, he successfully commercialized and launched Digital Micro fluidics based platform for screening and diagnosis of Rare Diseases and sample-prep platform for next generation sequencing, subsequently acquired by Illumina, Inc.. He also co-founded Aura Life, a natural product healthcare startup; and was in Business Development at MAXIMUS Federal. Srinivas is a graduate of Duke University, Fuqua School of Business with a MBA Degree, PhD in Zoology and Neurobiology from the University of Idaho and DVM from Acharya NG Ranga Agricultural University, College of Veterinary Science, Hyderabad, India. He has published several peer reviewed scientific papers.

      • Yuri D'Alessandra
        Sr. Researcher, Immunology and Functional Genomics Unit - Centro Cardiologico Monzino
        Biography

          Yuri D'Alessandra, Senior Researcher at Centro Cardiologico Monzino in Milan, Italy. He obtained his PhD in Genetic and Molecular Sciences at the University of Milan then moved to his current location in 2006. Since then, Yuri has been studying the role of microRNA in cardiovascular diseases. While the initial focus of his research was the regulation of cellular miRNAs upon hypoxic stimuli. Since 2008, Yuri shifted his interests on the presence of small non-coding RNAs in plasma. From then on, he has been analysing the possible role of plasma miRNAs as markers of heart disease such as myocardial infarction and heart failure. In 2014, thanks to the achievement of a national grant, he began to work on a project aimed at the molecular characterization of cardiotoxicity induced by anthracyclines. This led to the analysis of different models and samples taken from patients of the role of coding and non-coding RNAs in the response to anti-cancer treatments.

        • Anna Dominiczak, DBE MD FRCP FAHA FRSE FMedSci
          Regius Professor of Medicine, Vice Principal and Head of the College of Medical, Veterinary & Life Sciences - University of Glasgow
          Biography

            Professor Dame Anna Dominiczak is Regius Professor of Medicine, Vice Principal and Head of the College of Medical, Veterinary and Life Sciences at the University of Glasgow; Honorary Consultant Physician and Non-Executive Member of NHS Greater Glasgow and Clyde Health Board; and Health Innovation Champion for the Medical Research Council. In 2016, she was awarded a DBE for services to cardiovascular and medical science.

            Recognized as a world-leading cardiovascular scientist and clinical academic, her major research interests are in hypertension, cardiovascular genomics and precision medicine, where she not only publishes extensively in top peer-reviewed journals (over 500 publications), but also excels in large scale research funding for programmes and infrastructure (with a total value in excess of £100M over the last eight years).

            Professor Dominiczak is the driving force behind the fundraising, development and delivery of the University of Glasgow’s clinical academic campus at Queen Elizabeth University Hospital in Glasgow, home to a Clinical Innovation Zone from which she leads a triple helix partnership between academia, the NHS and industry to accelerate innovation, maximise patient benefit and stimulate business growth, including a collaboration of four Scottish universities, four NHS Health Boards across Scotland and two major industry partners in a public/private partnership focused on precision medicine.

            She is a Fellow of the Royal College of Physicians, the American Heart Association, the Academy of Medical Sciences, the Royal Society of Edinburgh, the European Society of Cardiology and the Society of Biology. From 2013 to 2015, she was President of the European Society of Hypertension. She is currently President of the Association of Physicians of Great Britain and Ireland.

          • Jami Elliott, MS, MBA
            Director, Business Development - Thermo Fisher Scientific
            Biography

              Jami Elliott is part of a clinical business strategy team within Thermo Fisher Scientific’s Genetic Sciences Division (GSD) where he directs new platform & test development for diagnostic segments. Jami is actively involved in CE-IVD and U.S.-IVD strategy development; as well as programs focused on Pharmacogenetics enabled medication therapy management, reimbursement and regulatory strategy.

            • Philip Empey, PharmD, PhD
              Director, Pharmacogenomics Center of Excellence; Associate Director, Institute for Precision Medicine - University of Pittsburgh
              Biography

                Dr. Philip Empey is the Associate Director of the Institute of Precision Medicine at the University of Pittsburgh and UPMC. He directs the Pharmacogenomics Center of Excellence and leads the PreCISE-Rx and Test2Learn teams to implement pharmacogenomics clinical, research, and educational initiatives. As a clinician-scientist in the Department of Pharmacy and Therapeutics of the School of Pharmacy, Dr. Empey conducts NIH-funded clinical and translational research aimed at understanding the mechanisms of the variability in drug response to improve medication-related outcomes in critically-ill patients. His research interests include large scale population preemptive testing, pharmacogenomics clinical implementation, collection of medication-related phenotype information, genotype-phenotype discovery, and understanding the role/impact of xenobiotic transporters following neurological injury.

              • Andrea Gaedigk, PhD
                Director, Pharmacogenomics Core Laboratory in the Division of Clinical Pharmacology & Medical Toxicology, Children's Mercy Kansas City; Professor of Pediatrics, University of Missouri-Kansas
                Biography

                  Dr. Gaedigk is a Professor of Pediatrics at Children’s Mercy in Kansas City where she directs the Pharmacogenetics Core Laboratory in the Division of Clinical Pharmacology and Therapeutic Innovation. Her work focuses on variation in pharmacogenes in diverse adult and pediatric populations in clinical and basic research. She is also directing the Pharmacogene Variation Consortium and closely works with the Pharmacogenomics KnowledgeBase and the Clinical Pharmacogenetics Implementation Consortium to promote the implementation of pharmacogenetics into clinical practice. In addition, she is a leading scientist of the GOLDILOKS program investigating variability in the metabolism and exposure to the ADHD drug atomoxetine.

                • Manoj Ghandi, MD, PhD
                  Sr. Director, Medical Affairs, Genetic Testing Solutions - Thermo Fisher Scientific
                  Biography

                    Dr. Manoj Gandhi received his medical degree and completed his residency in pathology at the University of Mumbai, India. He earned his PhD at the University of Cincinnati, Ohio followed by a post-doctoral fellowship at the University of Pittsburgh. He is a clinical and molecular pathologist with board certifications from the Medical Council of India. His previous positions were Lecturer and Associate Director of Transfusion Medicine at T.N. Medical College, Mumbai, as well as Instructor at the Division of Molecular Anatomic Pathology at University of Pittsburgh Medical Center.

                    Currently, Dr. Gandhi is the Senior Medical Director for the Genetic Testing Solutions business at Thermo Fisher Scientific and is part of the team that provides medical strategy, medical and scientific oversight for product development, on-market product support, and customer engagement. He has also held various leadership positions in the medical device and pharmaceutical industry, including at Affymetrix, Amgen, and Abbott Laboratories.

                  • Yesim Gokem-Polar, PhD
                    Associate Research Professor - Indiana University School of Medicine
                    Biography

                      Dr. Yesim Gökmen-Polar is an Associate Research Professor at the Department of Pathology and Laboratory Medicine at Indiana University School of Medicine. She obtained her PhD in Molecular Biology from Bogazici University, Istanbul, Turkey. After completing her postdoctoral work in Cancer Biology at the University of Texas Medical Branch, Galveston, Texas, she continued to concentrate on translational cancer biology first at the Department of Hematology & Oncology and then Pathology & Laboratory Medicine, Indiana University.

                      The primary focus of her research is the identification and characterization of novel therapeutic targets in breast and thymic cancers that are resistant to standard of care therapy. Her current research uses next generation sequencing (NGS), microarrays technologies, and preclinical models to understand the transcriptional regulation of RNA-binding proteins (RBPs) that contribute to resistance to endocrine therapies. Her work for the first time described a novel molecular function of a splicing factor (ESRP1) in poor prognostic ER+ breast cancer.

                      Dr. Yesim Gökmen-Polar has over 50 publications in Journals including EMBO Reports, Cancer Research and JNCI. She is the co-editor of the book entitled “Molecular Pathology of Breast Cancer” and serves as the Section Editor of Breast Cancer for Cancer Treatment and Research Communications (CTARC). She has developed, validated, patented gene signatures for thymoma and breast cancer. The ultimate goal of her research is to prevent development of resistance to therapies and improve the quality of life for patients.

                    • Derek Grillo
                      Sr Product Manager - Thermo Fisher Scientific
                      Biography

                        Derek Grillo joined Thermo Fisher Scientific in 2012, as a Global Product Manager with the Animal Health and Food Safety business. In 2017, his role expanded to include qPCR Reagents, focused on managing the 1-Step qPCR master mix portfolio. As a Sr. Global Product Manager, he is responsible for a wide range of qPCR workflow solutions products, including sample preparation products that support the Agribusiness market.

                        Derek has worked in a variety of functional areas, prior to joining Thermo Fisher including engineering, operations, and finance in the medical device industry. As a product manager he has successfully managed multiple product portfolios and successfully launched several, novel product innovations including the Applied Biosystems™ VetMAX™ Xeno™ Internal Positive Controls and MagMAX™ CORE Nucleic Acid Purification Kits. Most recently he has been involved in Thermo Fisher Scientific’s global response to COVID-19 testing by providing product support for the company’s end-to-end qPCR workflow solutions.

                        Derek is a graduate of Auburn University, with a BS degree in Mechanical Engineering and completed his graduate studies in Bioengineering from Clemson University. Derek is based in Austin, TX with his wife and three children.

                      • George Hii
                        Director, Global Market Development and Marketing, Reproductive Health - Thermo Fisher Scientific
                        Biography

                          George Hii is a well-rounded clinical business and life sciences commercial leader with over twenty years of deep experience covering Asia Pacific and global markets. He is currently the Director of Global Market Development for the Reproductive Health business of Thermo Fisher Scientific.

                          Prior to this, he held the role of Commercial Leader for Reproductive Health in the Asia Pacific region. George’s career includes over 6 years of experience at Illumina in the management of field applications and technical support, as well as five years as the Technical Director of the qPCR Core Facility at the Children’s Hospital of Philadelphia.

                          He graduated from Oklahoma State University in 1998 with a B.Sc. in biochemistry and a minor in microbiology. He successfully completed the executive education program at Wharton School of Business. George has an insatiable desire to improve human health through genetics. His career path has and continues to fulfill this goal every day.

                        • Scott Hunicke-Smith, PhD
                          Scientific Director - Clinical Pathology Laboratories
                          Biography

                            Dr. Hunicke-Smith joined Clinical Pathology Laboratories (CPL) January 2017 as Scientific Director after serving as the Vice President, Molecular R&D at the affiliated Sonic Reference Lab since September 2015. He manages test implementation, data science, and project management at CPL. Prior to joining Sonic, Dr. Hunicke-Smith was Director of the Genomic Sequencing and Analysis Facility (GSAF) at the University of Texas at Austin. He joined UT in August of 2008 to start next-generation sequencing (NGS) activities at UT and was instrumental in developing the bioinformatics curriculum at UT. Prior to joining UT, Dr. Hunicke-Smith was VP and General Manager of the molecular biology services’ division of Asuragen, a spin-out of Ambion. He joined in Ambion in July of 2003 as Director of Business Development, Instrumentation. He was promoted to Vice President, Business Development in March of 2004 and to Vice President, Ambion Services in September of 2005. Prior to joining Ambion, Dr. Hunicke-Smith served as founder and CEO of GeneMachines, a molecular biology equipment firm, from 1997 through March of 2003. Dr. Hunicke-Smith also served on the Board of Directors of Silicon Genetics, a bioinformatics software firm, from 1998 until acquired by Agilent in 2004 and on the Board of Directors of Bioo Scientific from 2010 until its acquisition in 2016. He received his Ph.D. in 1997 from Stanford University in the DNA Sequence and Technology Center run by Ron Davis, and is an inventor on seven issued US patents.

                          • Steve Jackson, PhD
                            Senior Manager, Product Applications - Thermo Fisher Scientific
                            Biography

                              Dr. Jackson has over 10 years of experience in genetic analysis technologies. As a senior member of the Content Engine R&D team at Thermo Fisher Scientific, he helps develop solutions for the research and healthcare markets, leveraging varied technologies such as capillary electrophoresis, digital PCR, next-generation sequencing, and microarray analysis. Before Thermo Fisher Scientific, he was at Nanostring Technologies running the Field Applications Specialist (FAS) team. He was also an Acting Assistant Professor at University of Washington, Department of Genome Sciences, investigating developmental genetics of Drosophila melanogaster.

                            • Steven J. Knapp
                              Professor and Director of the University of California, Davis Strawberry Breeding Program
                              Biography

                                Steven J. Knapp (Professor and Director of the University of California, Davis Strawberry Breeding Program) is an expert on plant breeding, quantitative genetics, and the application of genomics in plant breeding. His current research focuses on the breeding, genetics, and genomics of strawberry. His laboratory has been engaged in the development of genomic resources for octoploid strawberry, in addition to the development of cultivars for short-day, day-neutral, and summer-plant production systems worldwide. His previous research focused on the breeding, genetics, and genomics of sunflower, peanut, and industrial oilseeds. He was previously Global Director of Breeding Technology for the Vegetable Division at Monsanto (2009-2015), Professor and Georgia Research Alliance Eminent Scholar and Graduate Program Coordinator in the Institute of Plant Breeding, Genetics, and Genomics at the University of Georgia (2004-2009), and Professor and Paul C. Berger Endowed Chair at Oregon State University (1985-2004).

                              • Ohad Mazor, PhD
                                Head, the Department of Infectious diseases - IIBR
                                Biography

                                  1999-2004 - Ph.D. studies at the Weizmann Institute for Science, Rehovot, Israel. Thesis: Developing photodynamic-based drugs for cancer therapy.

                                  2004-2008 - Joined the Department of Biochemistry and Molecular Genetics in the Israel Institute for Biological Research (IIBR) as a research scientist and took part in the study that aimed at developing AChE as an organophosphate bioscavenger.

                                  2008-Present - Head, the antibody engineering group that focus on the development of recombinant therapeutic antibodies against toxins and bio-threat pathogens

                                  2017-present - Head, the Department of Infectious diseases, IIBR

                                • Laila Mnayer, MS, PhD, FACMG
                                  Division Director, Molecular Pathology & Cytogenetics - Hartford Hospital, Hartford Healthcare
                                  Biography

                                    Dr. Laila O. Mnayer is the Division Director of Molecular Pathology and Cytogenetics within the Department of Pathology at Hartford Hospital-Hartford Healthcare. She has been in this role since May 2006.

                                    Dr. Mnayer holds a Bachelor’s degree in medical technology and biological sciences and a Master’s degree in Embryology and Histology from the University of Jordan in Amman-Jordan. She received her Ph.D. in Biochemistry and Molecular Genetics from the School of Medicine, University of Miami, Miami-Florida. She also completed postdoctoral fellowships in Clinical Molecular Genetics at the University of Miami and in Clinical Cytogenetics at Tufts New England Medical Center, Boston, Massachusetts. She is board certified in Clinical Molecular Genetics and in Clinical Cytogenetics from the American Board of Medical Genetics and Genomics (ABMGG).

                                    Dr. Mnayer and her team provide molecular pathology and cytogenetics testing services for the entire Hartford Healthcare (HHC) Hospital System and Connecticut Children’s Medical Center (CCMC). She has designed, developed, and clinically validated numerous molecular and cytogenetic assays. Early on, she introduced and validated chromosomal microarrays for use in HHC molecular pathology labs. More recently she designed and validated multiple next-generation sequencing (NGS) panels in oncology and for germline testing that are offered across the HHC and CCMC systems. She has extensive expertise in test design, interpretation and reporting. She is also actively involved in teaching the residents and fellows in pathology at Hartford Hospital.

                                    Dr. Mnayer serves on several corporate advisory boards, has published multiple journal articles and book chapters, and has been the recipient of several awards.

                                  • Stewart G Neill, MD
                                    Assistant Professor, Pathology & Laboratory Medicine, Associate Director, Pathology Residency Program, Emory University
                                    Biography
                                      Dr. Stewart G. Neill received his MD degree from Emory University School of Medicine. He is currently an Assistant Professor of Pathology & Laboratory Medicine and Associate Director, Pathology Residency Program at Emory University.
                                    • Ronny Neinhold
                                      Group Head in Molecular Pathology - Institute of Pathology, Basel, Switzerland
                                      Biography

                                        Hello, I am Ronny Nienhold, head of the molecular pathology lab at Cantonal Hospital Baselland in Switzerland. Our focus is on cancer diagnostics and the pathology of infections.

                                        Before starting my academic career, I worked in the Pharma industry for three years as a lab technician. After my success at establishing a molecular cloning pipeline for proof-of-principle experiments in early drug development, I left industry to study Biology. During my PhD, I developed custom NGS workflows to elucidate the molecular background of myeloproliferative diseases.

                                        In molecular pathology, we routinely utilize NGS to characterize solid tumors, and PCR-based analyses to detect specific pathogens in human biopsies. In parallel to routine diagnostics, our lab performs molecular biological experiments to support translational research. Currently we are developing a metagenomics assays to screen for and identify pathogens hidden between thousands and thousands of human cells present in patient tissue samples.

                                      • Andy Peterson, PhD
                                        Chief Scientific Officer - MedGenome Inc.
                                        Biography

                                          Andy Peterson is currently the Chief Scientific Officer for MedGenome.

                                          He obtained his PhD in Genetics at Harvard University and did Postdoctoral work at University of California at San Francisco where genetics in somatic cells and in model organisms was his major research theme. In subsequent career stages, in faculty appointments at Duke University and UCSF, mouse genetics was used as an approach to understanding neural development and behavior. After joining Genentech in 2006, first as a Senior Scientist and eventually as Head of the Department of Molecular Biology, Dr Peterson led research infrastructure efforts in mouse genetics, next generation sequencing and genome engineering. He also led drug discovery efforts in Metabolic Disease and successfully introduced three molecules into Genentech's portfolio in that therapeutic area. Dr Peterson has over 30 years of research experience and a passion for helping individuals, organizations and societies use genetics to plan for good health.

                                        • Hannah Pezzi, PhD
                                          Staff Scientist, Genetic Testing Solutions - Thermo Fisher Scientific
                                          Biography

                                            Dr. Hannah Pezzi received her PhD in Biomedical Engineering from the University of Wisconsin-Madison. She has a strong background in molecular diagnostics and brings years of experience in nucleic acid extraction and qPCR. As R&D Scientist in the Genetic Testing Solutions business unit of Thermo Fisher Scientific, Hannah is responsible for system integration and translating manual processes into automated workflows.

                                          • Richard Pither, PhD
                                            CEO, Cytox Ltd, United Kingdom
                                            Biography
                                              Richard Pither has been involved in the development of diagnostic and therapeutic pharmaceutical products for more than 25 years. He has been CEO at Cytox for the past 7 years, a precision medicine working on developing and commercialising a new diagnostic technology for assessing Alzheimer's Disease risk. Prior to Cytox, Richard has held senior R&D and leadership positions in global pharmaceutical companies including GE Healthcare/Amersham plc, Lorantis and UCB-Celltech. During this time, he was involved in the development of a novel 18F-PET radiopharmaceutical for imaging amyloid deposition in the brains of Alzheimer's disease patients.
                                            • Saiju Pyarajan, PhD
                                              Director - Veteran Affairs
                                              Biography

                                                Saiju Pyarajan Ph.D. is the Director of the Center for Data and Computational Sciences at the VA Boston Healthcare System. He oversees the generation and curation of for the Million Veteran Program (MVP). Dr. Pyarajan completed his post-doctoral training from the Dana-Farber Cancer Institute and the NYU School of Medicine and obtained his Ph.D. in Immunology from University of Massachusetts, Amherst.

                                              • Fabien Ramos
                                                Supervisor, Manufacturing Operators - Thermo Fisher Scientific
                                                Biography

                                                  Fabien Ramos joined Thermo Fisher Scientific, in 2014, as a Team Leader Manufacturing and QC, in the AgriBusiness Vertical. Now in a role of Manufacturing Supervisor and Site Leader, he is responsible for the manufacturing and supply of Veterinary Diagnostics qPCR kits supporting AgriBusiness vertical – including VetMAX kits – and coordination of site activities including R&D, Supply Chain, Quality, Regulatory Affairs, Program Management and Sales & Support. Fabien is based in the Lissieu site, France.

                                                  Fabien brings broad experience to Thermo Fisher Scientific, with a strong combined R&D and Manufacturing background on Molecular Biology and Infectious diseases. He has developed qPCR kits within the VetMAX range of products and has been involved in ERP implementation activities, brand transition projects and site development projects. As a Manufacturing Supervisor, he successfully drive the growth of Manufacturing capacity in answer to customer demand, while ensuring Quality and Regulatory compliance.

                                                  Fabien is a graduate of Lyon 1 University, with a Master’s Degree, MSc in Cell Genetic and Oncology; and a Master’s Degree, MSc in Applied Infectiology

                                                • Timothy Rebbeck
                                                  Professor of Cancer Prevention at the Harvard T.H. Chan School of Public Health and the Dana-Farber Cancer Institute
                                                  Biography

                                                    Dr. Timothy Rebbeck is the Vincent L. Gregory, Jr. Professor of Cancer Prevention at the Harvard T.H. Chan School of Public Health and the Dana-Farber Cancer Institute. He is founding director of the Zhu Family Center for Global Cancer Prevention at the Harvard TH Chan School of Public Health and leads the Cancer Outreach and Engagement activities for the Dana-Farber Harvard Cancer Center. He leads molecular epidemiology studies to address problems of cancer etiology, prevention, outcomes, health disparities, and global health. His work has led to an understanding of the genetic and environmental causes of breast, prostate, skin, endometrial and ovarian cancers as well as interventions intended to reduce the burden of these cancers in individuals and populations. He founded and leads international cancer consortia that study risk and outcomes of 1) cancer in BRCA1/BRCA2 mutation carriers, and 2) prostate cancer in men of African descent in North America and Africa.

                                                  • Alain Rico
                                                    Sr Manager, Market Development - Thermo Fisher Scientific
                                                    Biography

                                                      Alain Rico is an engineer in biotechnology from the University of Marseilles, France. Member of the French Army Institute of Tropical Medicine, he worked on vaccine development studies in the fight against malaria. In 1997, he joined PE Biosystems now part of Thermo Fisher Scientific, a multinational science serving company. In charge of the market development for the Reproductive Health business and Precision Medicine solutions in EMEA, he is coordinating collaborations with key opinion leaders and development of innovative solutions, across all groups and divisions of the company and using the comprehensive offer of systems and reagents available in its portfolio. In 2011, as the scientific leader of the Application Development Team in EMEA, he sequenced the bacterial strain responsible for the EHEC outbreak using NGS (Ion Torrent), a world premiere.

                                                    • Anthony Schweitzer
                                                      Director, Expression Bioinformatics, Microarrays - Thermo Fisher Scientific
                                                      Biography

                                                        Anthony (Tony) Schweitzer is a Principal Scientist and Director of Bioinformatics for Expression Microarrays at Thermo Fisher Scientific. He provides expertise globally across the organization and has responsibilities in sales, marketing, product support, and R&D. He manages the Expression Bioinformatics Team and designs and develops next generation expression solutions. Tony actively participates in the US FDA SEQC/MAQC-III consortium and educates on the power and limitations of RNA-Seq. He has given lectures and seminars worldwide sharing insights on transcriptomics, biomarker discovery, and clinical use of microarrays for personalized medicine. He has developed a passion for aiding investigators with their research and clinical needs and empowering them with tools and insight normally beyond their capabilities.

                                                        Tony began his career in Columbus, Ohio working on large scale genomic efforts including progenitor stem cell research and pathogen detection. In 1997 he relocated to the San Francisco Bay Area and worked on clinical target discovery programs for large pharma and biotech in the areas of Asthma and Diabetes. In 1999 Tony became the Director of Bioinformatics and IT for Metabolex Inc. and began working with Affymetrix to develop custom Affymetrix expression arrays. In 2004 he brought his bioinformatics skills and knowledge to Affymetrix, heading up the Expression R&D informatics team and worked extensively on developing whole-transcriptome expression microarrays.

                                                      • Franz Seefried, PhD
                                                        Senior Geneticist - QUALITAS
                                                        Biography

                                                          Franz Seefried holds a position as senior geneticist at QUALITAS, the national evaluation center of IT and quantitative animal genetics for Swiss livestock. All through his career, he has been involved in designing pipelines and workflows in the field of genomic selection, especially for cattle. This role enabled his deep knowledge of analyzing large scale genotyping data. With his PhD in Animal Breeding received at TU Munich, he has been publishing and working in the field of applied and translational research. Thereby he has made significant contributions to several collaborative projects in the framework of animal breeding and population genetics.

                                                        • Jeffrey Shaman, PhD, MS
                                                          Chief Science Officer - Coriell Life Sciences
                                                          Biography

                                                            Jeffrey Shaman, PhD, MS, is the Chief Science Officer at Coriell Life Sciences where he oversees the company’s research, education, and clinical programs and leads efforts focused on bridging the gap between genetic science and clinical application. Dr. Shaman brings years of experience in advising cross-functional teams together with his scholarship in genetics, pharmacology, stem cells, and clinical laboratory operations. Along with the CEO, he forges strategic partnerships with worldwide companies, laboratories, academic institutions, public/private self-insured companies, and federal, state, and regional healthcare and employee systems.

                                                            Dr. Shaman supports a team of scientists dedicated to precision medicine and pharmacogenomics and who actively research, publish, and present findings in top-tier peer-reviewed journals. He is passionate about educating people from all backgrounds about the power of genetics and pharmacogenomic testing that is integrated with patient health history and clinical decision-support to proactively promote better health.

                                                            Dr. Shaman holds a doctoral degree from The Johns Hopkins University School of Medicine in Pharmacology and Molecular Sciences, where his research centered on DNA, epigenetics, and nuclear structure and function. He earned his Master of Science degree from The University of Medicine and Dentistry of New Jersey in Cell & Developmental Biology. Dr. Shaman held a faculty position at the University of Hawai‘i Institute of Biogenesis Research before serving a fellowship at Harvard Medical School and implementing a translational research program at Beth Israel Deaconess Medical Center and the Bedford Stem Cell Research Foundation.

                                                          • Vijay Singh, PhD
                                                            Managing Principal Scientist , Molecular Diagnostics, HealthTrack, Rx
                                                            Biography
                                                              Dr. Vijay Singh is the Managing Principal Scientist for Molecular Diagnostics at HealthTrackRx in Denton Texas where he has been in this role for 3 years. In his current role he is leading molecular tests for pathogen targets on qPCR nanofluidics platform. Prior to this role he did his PhD in Molecular Biology and Post-Doctoral training in Metabolic Engineering at University of North Texas.
                                                            • Harita Veereshlingam, PhD
                                                              Senior Product Application Scientist, Genetic Sciences Division - Thermo Fisher Scientific
                                                              Biography

                                                                Harita Veereshlingam is a Senior Product Application Scientist in the Genetic Sciences Division at Thermo Fisher Scientific. She has over 10 years of experience in product development with an emphasis on real time PCR assays for gene expression and miRNA analysis. In her current role, Harita is responsible for product portfolio growth through the development of novel applications, customer collaborations, technical notes, and webinars. She lives by and is a strong proponent of sustainable living. She has a PhD in Molecular Biology from the University of North Texas.

                                                              • Paul R. Walker, MD, FACP
                                                                Chief Medical Officer - Circulogene
                                                                Biography

                                                                  Dr. Paul Walker is a graduate of the Indiana University School of Medicine and Associate Professor Emeritus at the Brody School of Medicine at East Carolina University in Greenville, NC, where he served as Director of Thoracic Oncology and Director of the Hematology/Oncology Fellowship Program. He currently is Chief Medical Officer of Circulogene. Published cancer research has focused on immune therapy dating back to IL-2, immune checkpoint blockade in combination with ablative radiation therapy, managing immune toxicities and racial disparities in lung cancer treatment. Current research focus is the clinical utility of liquid biopsies in early stage lung cancers and integrating non-driver co-mutations into cancer treatment decision making.

                                                                • David C. Whitcomb, MD, PhD, FACP, FACG, AGAG
                                                                  Professor, Co-Founder Ariel Precision Medicine - Ariel Precision Medicine
                                                                  Biography

                                                                    Professor David C. Whitcomb MD PhD is a pioneer in the use of mathematics, genetics, neurosciences, immunology, epidemiology and clinical sciences to study complex inflammation disorders and cancer risks of the digestive system, and he is among the most-cited authors in the field of pancreatic diseases with multiple landmark papers. He co-founded the Center for Genomic Sciences at the University of Pittsburgh (now part of the Genomics and Proteomics Core Laboratory), and served as Director of the Nutrition Support Service and Director of Gastroenterology for the Pittsburgh VA Healthcare System. He served as Chief, Division of Gastroenterology, Hepatology and Nutrition at the University of Pittsburgh from 1999 to 2016, building it into a top-tier Gastroenterology program. With over 25 years of continuous NIH funding, he served as principal investigator on multiple National Institutes of Health-sponsored studies, building one of the top human genetics programs for complex digestive diseases. He as published over 400 papers, reviews and book chapters with nearly 30,000 citations, and h-index of ~ 85 and i10index of ~280. His research, education and organizational innovations in precision medicine continue to be studied and emulated by other leading programs throughout the world. Dr. Whitcomb completed a doctorate in physiology (PhD, 1983) and a medical degree (MD, 1985) at Ohio State University. Postdoctoral training at Duke University included medical residency, gastroenterology fellowship and postdoctoral training under Ian Taylor MD PhD. Dr. Whitcomb joined the faculty of the University of Pittsburgh and UPMC as a physician-scientists in 1991. He holds the Giant Eagle Foundation Professor of Cancer Genetics (endowed chair), Professor of Medicine (with tenure), Professor of Cell Biology & Molecular Physiology, and Professor of Human Genetics. He is also Adjunct Professor of Biomedical Engineering at Carnegie Mellon University, Pittsburgh, PA. Professor Whitcomb is Editor-in-Chief of Clinical and Translational Gastroenterology, an official journal of the American College of Gastroenterology (ACG), and Section Editor for Pancreas, UpToDate. Dr. Whitcomb has served as president of the American Pancreatic Association (APA) and Chairman of the Pancreatic Disorders Section of the American Gastroenterology Association (AGA). He co-founded and has led the Midwest Multicenter Pancreatic Study Group, the North American Pancreatic Study Group (NAPS2) and the Collaborative Alliance for Pancreatic Education and Research (CAPER). He started and directs PancreasFest, an annual international translational meeting every July in Pittsburgh. He has been recognized by his peers with four different national and international lifetime achievement, mentoring and/or service awards. Recognizing the failures of effective treatment of chronic pancreatitis, Dr. Whitcomb has championed the idea of precision medicine for complex chronic disorders. Since disruptive technologies are not embraced by established enterprises that do not disrupted, Dr. Whitcomb co-founded Ariel Precision Medicine, an independent, genomic-health information technology company to deliver precision medicine for patients who need it. He serves Ariel Precision Medicine as a consultant, Chair of the medical advisory board and sits on the board of directors.

                                                                  • Steve Williams
                                                                    R&D Leader, Capillary Electrophoresis - Thermo Fisher Scientific
                                                                    Biography

                                                                      Steve Williams is the leader of the capillary electrophoresis R&D group at Thermo Fisher Scientific. He has extensive experience in developing and commercializing capillary electrophoresis instrumentation and applications related to genetic analysis. Prior to working at Thermo Fisher Scientific, Steve has experience in the fields of human identification, oncology diagnostics, sample-to-answer devices and microfluidics. Steve holds a PhD in Analytical Chemistry from the University of York, UK and held post-doctoral positions at Genentech and the University of California, Berkeley.

                                                                    • Li Xiang, PhD
                                                                      Technical Manager from China Animal Husbandry Group
                                                                      Biography

                                                                        Dr. Lixiang graduated from China Agricultural University, receiving his education and carrying out researches on Virology and Immunology. After that, he Joined China Animal Husbandry Group in Jul. 2013, firstly served as an export specialist working on CAHG home produced API(active pharmaceutical ingredients), and then he moved to animal health department as technical manager when CAHG starting cooperation with Thermo Fisher Scientific on animal diseases diagnosis business.

                                                                        With his strong life science background, Dr. Lixiang have provided extensive technical support to the local laboratories of animal husbandry enterprises, especially after the outbreak of African Swine Fever in China.

                                                                      C.E. Credits

                                                                      The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here